US FDA approves Gilead's liver disease drug-March 2024-www.financetom.com

US FDA approves Gilead's liver disease drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Gilead's liver disease drug

Aug 14, 2024 10:35 AM

Aug 14 (Reuters) - The U.S. Food and Drug Administration

said on Wednesday it has approved Gilead Sciences' ( GILD ) drug

for a chronic and potentially fatal liver disease that mostly

affects women.

The disease, primary biliary cholangitis (PBC), causes

inflammation of the small bile ducts in the liver and can

eventually destroy them. It mainly affects women aged 35 to 60.

Previous page： National Vision Holdings Preliminary Fiscal Q4 Revenue Rises; CFO to Depart Next page： Soccer-Diallo hat-trick drags Man United to comeback win over Southampton

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

National Vision Holdings Preliminary Fiscal Q4 Revenue Rises; CFO to Depart

Jan 16, 2025

05:23 PM EST, 01/16/2025 (MT Newswires) -- National Vision Holdings ( EYE ) said preliminary data showed fiscal Q4 net revenue from continuing operations rose 3.9% to $437 million from a year earlier. Analysts polled by FactSet expect revenue of $432.8 million. Results from Q4 and fiscal 2024 are scheduled for Feb. 26, the company said Thursday in a statement....

Soccer-Diallo hat-trick drags Man United to comeback win over Southampton

Jan 16, 2025

MANCHESTER, England, Jan 16 (Reuters) - Three late goals from Amad Diallo dragged a below-par Manchester United ( MANU ) to an unlikely 3-1 comeback victory over bottom side Southampton in the Premier League on Thursday. United will have fancied their chances of getting back to winning ways against struggling Saints but the hosts were second best from the off,...

Canadian Western Bank Terminates Dividend Reinvestment Plan

Jan 16, 2025

05:19 PM EST, 01/16/2025 (MT Newswires) -- Canadian Western Bank ( CWESF ) after trade Thursday said it is canceling its dividend reinvestment plan (DRIP) effective immediately, ahead of its acquisition by National Bank of Canada (NA.TO). The plan agent under the DRIP, Computershare Trust Company of Canada, will send each participant a DRS Advice for whole CWB shares held...

SEC settles charges against US hedge fund over investment model vulnerabilities

Jan 16, 2025

WASHINGTON (Reuters) - The U.S. Securities and Exchange Commission on Thursday settled charges against hedge fund Two Sigma over failure to address known vulnerabilities in its investment models, the regulatory agency said. Two Sigma voluntarily repaid $165 million to impacted funds and accounts during the SEC's investigation and agreed to pay $90 million in civil penalties to settle the SEC's...